Conference
Phase II trial of WT1 analog peptide vaccine in adults with acute myeloid leukemia (AML) in first complete remission (CR).
Authors
Maslak PG; Dao T; Bernal Y; Chanel SM; Zhang R; Frattini MG; Rosenblat TL; Jurcic JG; Rampal R; Park JH
Volume
34
Pagination
pp. 7005-7005
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
May 20, 2016
DOI
10.1200/jco.2016.34.15_suppl.7005
Conference proceedings
Journal of Clinical Oncology
Issue
15_suppl
ISSN
0732-183X